| Financial Year |
March 31 2022 |
| Monetary Funds |
36,631,377,609.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,170,668,385.56 |
| Accounts Receivable |
63,467,507,693.40 |
| Advances to Suppliers |
3,447,051,382.89 |
| Other Receivables |
2,176,087,745.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
60,061,164.66 |
| Inventories |
25,441,363,088.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
121,434,319.05 |
| Other Current Assets |
800,050,106.18 |
| Total Current Assets |
134,867,871,229.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
216,551,291.20 |
| Long-term Equity Investment |
9,439,565,088.84 |
| Investment Properties |
206,685,085.73 |
| Fixed Assetes |
10,247,366,116.67 |
| Under-construction Projects |
3,357,436,743.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
402,200,895.82 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,947,722,744.69 |
| R&D expenses |
242,146,143.94 |
| Goodwill |
11,241,077,206.34 |
| Long-Term Deferred and Prepaid Expenses |
419,369,147.44 |
| Deferred Income Tax Assets |
1,359,946,410.48 |
| Other Non-Current Assets |
746,738,613.37 |
| Sub-Total of Non-Current Assets |
47,155,424,937.69 |
| Total Assets |
182,023,296,167.44 |
| Short-Term Loans |
27,407,274,832.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,440,204,750.20 |
| Accounts Payable |
38,425,639,930.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
963,568,494.38 |
| Taxes Payable |
1,276,479,502.60 |
| Interest Payable |
-- |
| Dividend Payable |
362,834,526.81 |
| Other payables |
11,970,630,882.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
769,891,083.67 |
| Other Current Liabilities |
9,168,042,694.97 |
| Sub-Total of Current Liabilities |
95,214,624,390.32 |
| Long-term Loans |
7,058,108,639.14 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
321,898,478.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
23,243,898.02 |
| Deferred Income Tax Liabilities |
983,613,608.69 |
| Other Non-Current Liabilities |
295,117,671.66 |
| Sub-Total of Non-Current Liabilities |
12,429,587,950.44 |
| Total Liabilities |
107,644,212,340.76 |
| Paid-In Capital(Or Share Stock) |
3,695,507,249.00 |
| Capital Surplus |
29,169,530,827.62 |
| Surplus Reserve |
1,992,463,708.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
29,849,616,692.59 |
| Minority Stockholder's Interest |
9,856,868,798.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
64,522,215,028.50 |
| Owner's Equity（Stockholder's Equity） |
74,379,083,826.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
182,023,296,167.44 |
